Prediction of LncRNA-Disease Associations Based on Network Consistency Projection

A growing body of research has uncovered the role of long noncoding RNAs (lncRNAs) in multiple biological processes and tumorigenesis. Predicting novel interactions between diseases and lncRNAs could help decipher disease pathology and discover new drugs. However, because of a lack of data, inferrin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:IEEE access 2019, Vol.7, p.58849-58856
Hauptverfasser: Li, Guanghui, Luo, Jiawei, Liang, Cheng, Xiao, Qiu, Ding, Pingjian, Zhang, Yuejin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A growing body of research has uncovered the role of long noncoding RNAs (lncRNAs) in multiple biological processes and tumorigenesis. Predicting novel interactions between diseases and lncRNAs could help decipher disease pathology and discover new drugs. However, because of a lack of data, inferring disease-lncRNA associations accurately and efficiently remains a challenge. In this paper, we present a novel network consistency projection for LncRNA-disease association prediction (NCPLDA) model by integrating the lncRNA-disease association probability matrix with the integrated disease similarity and lncRNA similarity. The lncRNA-disease association probability matrix is calculated based on known lncRNA-disease associations and disease semantic similarity. The integrated disease similarity and lncRNA similarity are computed based on disease semantic similarity, lncRNA functional similarity and Gaussian interaction profile kernel similarity. In leave-one-out cross validation experiments, NCPLDA achieved outstanding AUCs of 0.8900, 0.8996, and 0.9012 for three datasets. Furthermore, prostate cancer and ovarian cancer case studies demonstrated that the NCPLDA can effectively infer undiscovered lncRNAs.
ISSN:2169-3536
2169-3536
DOI:10.1109/ACCESS.2019.2914533